Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
about
Problems monitoring response in multiple myelomaProteomics in molecular diagnosis: typing of amyloidosisDual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis.Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.Guideline of transthyretin-related hereditary amyloidosis for clinicians.A binding-site barrier affects imaging efficiency of high affinity amyloid-reactive peptide radiotracers in vivoMicro-imaging of amyloid in mice.A 70-Year-Old Man With Large Cervical and Mediastinal Lymphadenopathies.Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT.Pathogenetic mechanisms of amyloid A amyloidosis.Renal amyloidosis in children.Neuropathy and paraproteins: review of a complex association.Cardiac amyloidosis: the heart of the matter.Molecular imaging of amyloidosis: will the heart be the next target after the brain?18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review.How to diagnose amyloidosis.Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction.Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.Cardiac amyloidosis: can advances in diagnostics and treatments improve survival?Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis.Guidelines on the diagnosis and management of AL amyloidosis.Pretargeting immunotherapy: a novel treatment approach for systemic amyloidosis.Guidelines for the use of imaging in the management of myeloma.Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.Guidelines on the diagnosis and investigation of AL amyloidosis.Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathyFluorine-18 labeled fluorodeoxyglucose PET useful for therapy monitoring in localized AL amyloidosis?Spontaneous perirenal hematoma with AA amyloidosis in a hemodialysis patient after unilateral nephrectomyAdditional diagnostic value of SPECT/CT to planar Iodine-123 labeled serum amyloid P component scintigraphy in a patient with pulmonary nodular amyloidosisRenal Transplantation in Systemic Amyloidosis-Importance of Amyloid Fibril Type and Precursor Protein Abundance
P2860
Q24676888-8EFC7081-0DE2-4C64-B17E-6A629E92D0CAQ26823596-9AA29254-A133-432C-A305-872B08490F5FQ33793266-C62E214D-99C7-487B-86B2-C89C3D483A6BQ34216798-F34A2DE1-17C2-4F1B-A19C-6A075A42F182Q34328734-77F46544-EEBE-4D7E-A60D-1A65238ABE73Q34764389-658768F2-0C37-4A6F-AA7B-2311F9AA91EBQ35652050-305C64C6-4E89-4D85-8217-CBAE76DE7108Q36411335-95318657-B82A-4F3B-96D0-86B385355976Q36877784-0D461AE8-BA0E-4F76-9EB4-6991DE022913Q37218553-8231B1BB-77AF-4BD9-A275-AC718B5FD290Q37848210-9AE55A86-9C93-4FE4-B50E-F29653EECB16Q37854873-9AC8A00D-18C7-4128-9A9E-E896F7A1D67CQ37899075-9C6D6429-7B84-406D-B31D-BBAB4C791202Q37970935-45C43633-FBD1-46C2-BEF3-9C8984A1480CQ38010222-F482E6D0-66FF-4593-B026-18D37B2F3230Q38136289-028D1EB8-54B7-4F73-BB1C-670CE78F9A12Q38450940-E8A2E45A-3BD1-4204-A5F0-90CA62977793Q40737924-584A712A-7C72-473C-BDBA-001F08862459Q41891100-5BF8CA3A-0ED4-4B81-89DF-F1144D6BF30BQ44478247-F75FBA1D-B50A-4FBF-BC94-48053DDC2998Q44924110-F17C03FE-7227-40B2-A65F-657963724C05Q47927900-F05A482F-A569-4C14-B9C8-E6B04A42564CQ53494589-FD941E1F-0682-4A27-9080-22625A590DD0Q53568258-76E4CCBC-E326-4F60-BB1D-1531A301EBB3Q55041793-DABEC5AC-12A5-4BDF-8BB6-366C4DC26E97Q55058605-1602622D-F181-4028-9E1C-11BE408AD589Q56986496-D80DD6B2-09BF-4E53-B86B-73C53F0F48EEQ58124886-8E5F8181-E5F9-4616-A073-A3F30C4FB9CAQ58295363-C2D132F4-7377-4E1C-96DA-E551D9F291F1Q58308744-96D821D7-5CD6-4968-AD05-1E28B874828EQ58853072-2236F14F-04BE-4C47-80CE-878197922977
P2860
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@ast
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@en
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@nl
type
label
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@ast
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@en
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@nl
prefLabel
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@ast
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@en
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@nl
P1476
Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis.
@en
P2093
Philip N Hawkins
P304
P356
10.1097/00041552-200211000-00013
P577
2002-11-01T00:00:00Z